Come up with a name for your new list and we'll add to it:
Portola Pharmaceuticals raised a round of funding on October 27, 2011. Investors include
Biogen Idec New Ventures.
Portola is a biopharmaceutical company focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who curren…